Skip to main content
. 2013 Aug 19;14:261. doi: 10.1186/1745-6215-14-261

Figure 1.

Figure 1

ADAPT CONSORT flow diagram. Patients are allocated to one of four distinct ADAPT sub-trials, depending on the hormone receptor (HR) and HER2 status of the tumor. Randomization is always subject to the respective sub-trial after allocation. Patients will be treated subtype-specific according to their individual disease. Follow-up is scheduled for five years following registration.